FDANonrulemakingFDA-2017-D-5625

Who commented on this docket

Recommendations for Dual 510(k) and CLIA Waiver by Application Studies; Draft Guidance for Industry and Food and Drug Administration Staff; Availability

1 organizations filed 1 public comment on Recommendations for Dual 510(k) and CLIA Waiver by Application Studies; Draft Guidance for Industry and Food and Drug Administration Staff; Availability, at the Food and Drug Administration. The comment window closed 2708d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 2708d ago

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.